W. Va. attorney general investigates Mylan over potential antitrust violations, Medicaid fraud

West Virginia Attorney General Patrick Morrisey (R) launched an investigation on Mylan over potential antitrust violations and state Medicaid fraud, reported USA Today.

Mr. Morrisey issued a subpoena to Mylan on Aug. 26 seeking answers over EpiPen price hikes, but the drugmaker failed to provide all requested information by the Sep. 7 deadline. In response, Mr. Morrisey filed a petition on Tuesday in the Circuit Court of Kanawha County requesting court enforcement of the subpoena.

The subpoena calls for information that would prove whether Mylan underpaid for rebate amounts needed to participate in West Virginia's Medicaid program, according to the report. It also asks for information regarding the drastic price increase of EpiPens.

"I have a statutory responsibility to investigate any potential antitrust violation," Mr. Morrisey said in a written statement. "My office owes it to consumers to be their watchdog and turn over every rock to ensure fair play."

Canonsburg, Pa.-based Mylan claimed it could not provide Mr. Morrisey with further information until after its Capitol Hill hearings, which "could continue for weeks," the petition said.

Mylan CEO Heather Bresch is due to appear before the U.S. House Committee on Oversight and Government Reform Wednesday to explain why EpiPens, which cost $57 per pen in 2007, now run for more than $600 for a two-pack.

More articles on supply chain:

Siemens CEO: Geopolitical instability will hurt business
J&J to acquire Abbott's eye surgery unit: 5 things to know
Jimmy Kimmel's EpiPen joke calls out high drug prices at Emmys

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars